Article
Interpreting new molecular genetics in myelodysplastic syndromes.
Hematology. American Society of Hematology. Education Program - 1 Jan 2012
Abdel-Wahab Omar, Figueroa Maria E
Abstract excerpt
The myelodysplastic syndromes (MDS) are a clinically and cytogenetically heterogeneous group of clonal diseases characterized by ineffective hematopoiesis, peripheral blood cytopenias, and an increased risk of progression to acute myeloid leukemia. The precise molecular mechanisms behind the development of MDS have remained elusive; however, the distinct sensitivity of this disease to DNA methyltransferase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
